The Lancet thelancet.com

[Articles] Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 stu...

thelancet.com·27w

[Comment] Bundled interventions to prevent acute kidney injury: finding the value in supportive care

thelancet.com·27w

[Review] Hyperemesis gravidarum

thelancet.com·27w

[Correspondence] El Fasher crisis: over 500 days under siege amid global inaction

thelancet.com·27w

[Correspondence] El Fasher crisis: over 500 days under siege amid global inaction

thelancet.com·27w

[Review] Hyperemesis gravidarum

thelancet.com·27w

[Articles] A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical tria...

thelancet.com·27w

[Comment] Bundled interventions to prevent acute kidney injury: finding the value in supportive care

thelancet.com·27w

[Comment] The Lancet MedZero: carbon analytics for health care, by health care, at scale

thelancet.com·27w

[Comment] Exploring CAR NK-cell therapy for refractory lupus

thelancet.com·27w

[Articles] Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China

thelancet.com·27w

[Articles] Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China

thelancet.com·27w

[Comment] Exploring CAR NK-cell therapy for refractory lupus

thelancet.com·27w

[Articles] Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, pl...

thelancet.com·27w

[Comment] Closing the deal: a G20 panel report on financing for pandemic threats

thelancet.com·27w

[Comment] Personalised prevention therapy in type 1 diabetes

thelancet.com·27w

[Articles] Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multic...

thelancet.com·27w

[Articles] Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multic...

thelancet.com·27w

[Comment] Complete revascularisation in patients with acute myocardial infarction

thelancet.com·27w

[Comment] Why cash transfers matter for global health—now more than ever

thelancet.com·27w

Log in to enable infinite scrolling